| Stage | CMCSA | % of rev | BKNG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $29.3B | 100.00% | $7.4B | 100.00% | CMCSA ×3.99 |
| Gross profit | $21.8B | 74.35% | $7.4B | 100.00% | BKNG +25.7pp |
| Operating income | $5.3B | 18.16% | $2.5B | 34.00% | BKNG +15.8pp |
| Pre-tax income | $4.4B | 15.18% | $2.6B | 34.82% | BKNG +19.6pp |
| Net income | $3.4B | 11.48% | $1.9B | 26.52% | BKNG +15.0pp |
| Stage | CMCSA | BKNG | Gap · A − B |
|---|---|---|---|
| Revenue | $29.3B100.00% | $7.4B100.00% | CMCSA ×3.99 |
| Gross profit | 74.35%$21.8B | 100.00%$7.4B | BKNG +25.7pp |
| Operating income | 18.16%$5.3B | 34.00%$2.5B | BKNG +15.8pp |
| Pre-tax income | 15.18%$4.4B | 34.82%$2.6B | BKNG +19.6pp |
| Net income |
| 11.48%$3.4B |
| 26.52%$1.9B |
| BKNG +15.0pp |
No shared counterparties.